EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The Effect of N‐Acetylcysteine ( NAC ) on Neurometabolites and Cognitive Function in Adults With Alcohol Use Disorder: A Preliminary Randomized Controlled Trial

Kristiane Yacou Dunbar, Gezelle Dali iD, Marilena M DeMayo, Warren Logge iD, Tristan Hurzeler, Catherine Kelly, Joshua Watt, Lindsay M Squeglia iD, Anna E Kirkland iD, Paul S Haber iD, Kirsten C Morley iD

Neuropsychopharmacology Reports · 2025

DOI: 10.1002/npr2.70066 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Neuropsychopharmacology Reports, 2025. Verfasst von Kristiane Yacou Dunbar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Specialty of Addiction Medicine, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Acetylcysteine, Cognition, Alcoholism, Gyrus Cinguli. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Preclinical studies have demonstrated that N‐acetylcysteine stabilizes levels of glutamate and glutathione and reduces alcohol‐seeking behaviors, indicating it as a potential pharmacotherapy for the management of alcohol use disorder. In this preliminary study, we examined brain metabolite levels and cognitive functioning in individuals with alcohol use disorder enrolled in a randomized controlled trial of N‐acetylcysteine versus placebo.

Methods

In this preliminary trial, 23 participants (average age = 49; 70% male) with moderate to severe alcohol use disorder (DSM‐5) were randomized to receive 2400 mg/day of N‐acetylcysteine ( N = 9) or placebo ( N = 14). At baseline and follow‐up ( M = 19 days; SD = 3.73 days post‐baseline), participants underwent proton magnetic resonance spectroscopy ( 1 H‐MRS) to assess levels of glutamate (Glu), glutathione (GSH) and total N‐acetylaspartate (tNAA) in the anterior cingulate cortex (ACC) and completed the Stroop Color and Word Test (SCWT; a measure of distractor interference and cognitive control) and the Trail Making Test (TMT; a measure of set shifting ability).

Results

There were no significant differences between the N‐acetylcysteine or placebo groups in neurometabolite concentrations (GSH/Cr: p = 0.75, CI; −0.12–0.09, tNAAG/Cr: p = 0.797, CI; −0.10–0.13, Glu/Cr: p = 0.60, CI; −0.19–0.32), or cognitive scores (Stroop: p = 0.57, CI; −306.93–172.78, TMT: p = 0.166, CI; −6.62–36.77).

Conclusion

These preliminary findings indicate that N‐acetylcysteine may not alter brain neurometabolite levels within the ACC or show improvements in certain domains of cognitive functioning measured by the SCWT and TMT, specifically resistance to distractor interference and set‐shifting ability respectively, in individuals with alcohol use disorder. Trial Registration ClinicalTrials.gov identifier: NCT03879759

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetylcysteineCognitionAlcoholismGyrus CinguliHumansMaleFemaleMiddle AgedAdultGlutamic AcidGlutathioneAspartic AcidDouble-Blind MethodProton Magnetic Resonance Spectroscopy

Stichwörter der Autor:innen

NAAN‐acetylcysteinealcohol use disorderglutamateglutathionemagnetic resonance spectroscopyneurometabolitespharmacotherapy

Substanzen

AcetylcysteineN-acetylaspartateGlutamic AcidGlutathioneAspartic Acid

Autor:innen und Institutionen

  • Specialty of Addiction Medicine, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
  • Edith Collins Centre for Translational Research (Alcohol, Drugs & Toxicology), Royal Prince Alfred Hospital, Sydney Local Health District, Sydney, New South Wales, Australia.
  • Department of Radiology and Department of Psychiatry, University of Calgary, Calgary, Alberta, Canada.
  • Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.

ORCID-Profile: Gezelle Dali, Warren Logge, Lindsay M Squeglia, Anna E Kirkland, Paul S Haber, Kirsten C Morley

Förderung

  • National Health and Medical Research Council
  • University of Sydney

Zitieren

APA

Dunbar, K. Y., Dali, G., DeMayo, M. M., Logge, W., Hurzeler, T., Kelly, C., Watt, J., Squeglia, L. M., Kirkland, A. E., Haber, P. S., & Morley, K. C. (2025). The Effect of N‐Acetylcysteine ( NAC ) on Neurometabolites and Cognitive Function in Adults With Alcohol Use Disorder: A Preliminary Randomized Controlled Trial. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.70066

Vancouver

Dunbar KY, Dali G, DeMayo MM, Logge W, Hurzeler T, Kelly C, et al. The Effect of N‐Acetylcysteine ( NAC ) on Neurometabolites and Cognitive Function in Adults With Alcohol Use Disorder: A Preliminary Randomized Controlled Trial. Neuropsychopharmacology Reports. 2025. doi:10.1002/npr2.70066

BibTeX
@article{Dunbar2025,
  author = {Dunbar, Kristiane Yacou and Dali, Gezelle and DeMayo, Marilena M and Logge, Warren and Hurzeler, Tristan and Kelly, Catherine and Watt, Joshua and Squeglia, Lindsay M and Kirkland, Anna E and Haber, Paul S and Morley, Kirsten C},
  title = {The Effect of N‐Acetylcysteine ( NAC ) on Neurometabolites and Cognitive Function in Adults With Alcohol Use Disorder: A Preliminary Randomized Controlled Trial},
  journal = {Neuropsychopharmacology Reports},
  year = {2025},
  doi = {10.1002/npr2.70066}
}
Kostenlos starten →